Description
CPI-1189 prevents apoptosis and reduces glial fibrillary acidic protein immunostaining in a TNF-alpha infusion model for AIDS dementia complex.
CPI-1189 prevents apoptosis and reduces glial fibrillary acidic protein immunostaining in a TNF-alpha infusion model for AIDS dementia complex.
Alternate Name/Synonyms: 4-Acetamido-N-tert-butylbenzamide
Appearance: Crystalline solid
Formulation: N/A
CAS Number: 183619-38-7
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₁₃H₁₈N₂O₂
Molecular Weight: 234.14
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: DMSO
Handling: Protect from air and light
Country of Origin: USA
Tag Line: An apoptosis inhibitor
MDL Number: N/A
PubChem CID: 151118
SMILES: CC(=O)NC1=CC=C(C=C1)C(=O)NC(C)(C)C
InChi: InChI=1S/C13H18N2O2/c1-9(16)14-11-7-5-10(6-8-11)12(17)15-13(2,3)4/h5-8H,1-4H3,(H,14,16)(H,15,17)
InChi Key: DJKNRCWSXSZACF-UHFFFAOYSA-N
Additional Information
Storage Condition: |
-20°C |
Shipping Condition: |
Gel Pack |
Shelf Life: |
36 months |